Arkolith/Insider Trading/JANX/Form 4

Dobek Maria

Vice President, AccountingJanux Therapeutics, Inc. (JANX) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Sell(S)2K$14.17$29K32K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002032671-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML